0001127602-18-019981.txt : 20180605 0001127602-18-019981.hdr.sgml : 20180605 20180605150759 ACCESSION NUMBER: 0001127602-18-019981 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180601 FILED AS OF DATE: 20180605 DATE AS OF CHANGE: 20180605 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sheridan William P CENTRAL INDEX KEY: 0001439174 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23186 FILM NUMBER: 18880892 MAIL ADDRESS: STREET 1: 2190 PARKWAY LAKE DR CITY: BIRMINGHAM STATE: AL ZIP: 35244 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOCRYST PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000882796 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 621413174 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4505 EMPEROR BOULEVARD STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 BUSINESS PHONE: 919-859-1302 MAIL ADDRESS: STREET 1: 4505 EMPEROR BOULEVARD STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2018-06-01 0000882796 BIOCRYST PHARMACEUTICALS INC BCRX 0001439174 Sheridan William P 4505 EMPEROR BLVD. SUITE 200 DURHAM NC 27703 1 Senior VP - CMO Common Stock 2018-06-01 4 M 0 42112 2.58 A 63170 D Common Stock 2018-06-01 4 S 0 42112 6.30 D 21058 D Emp. Stock Option (Right to Buy) 2.58 2018-06-01 4 M 0 42112 0 D 2009-07-01 2018-07-01 Common Stock 42112 0 D This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2017 and due to the upcoming expiry of the option. The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $6.23 to $6.46. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. /s/ Alane P. Barnes, by power of attorney 2018-06-05